These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 7577142)

  • 41. Treatment with the tumor necrosis factor-alpha-inducing drug 5,6-dimethylxanthenone-4-acetic acid enhances the antitumor activity of the photodynamic therapy of RIF-1 mouse tumors.
    Bellnier DA; Gollnick SO; Camacho SH; Greco WR; Cheney RT
    Cancer Res; 2003 Nov; 63(22):7584-90. PubMed ID: 14633671
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of filgrastim on the pharmacokinetics of MX2 hydrochloride in patients with advanced malignant disease.
    Morgan DJ; Hill JS; Clarke K; Stylli SS; Park SJ; Cebon J; Basser RL; Kaye AH; Geldard H; Maher DW; Green MD
    Cancer Chemother Pharmacol; 1998; 41(5):423-6. PubMed ID: 9523740
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fluorescent diagnosis and photodynamic therapy for C6 glioma in combination with antiangiogenic therapy in subcutaneous and intracranial tumor models.
    Tzerkovsky DA; Osharin VV; Istomin YP; Alexandrova EN; Vozmitel MA
    Exp Oncol; 2014 Jun; 36(2):85-9. PubMed ID: 24980761
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Therapeutic effects of photosensitizers in combination with laser and ACNU on an in vivo or in vitro model of cerebral glioma.
    Chen KT; Hau DM; You JS; Pan HC; Wong RW
    Chin Med J (Engl); 1995 Feb; 108(2):98-104. PubMed ID: 7774398
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tumor vascular response to photodynamic therapy and the antivascular agent 5,6-dimethylxanthenone-4-acetic acid: implications for combination therapy.
    Seshadri M; Spernyak JA; Mazurchuk R; Camacho SH; Oseroff AR; Cheney RT; Bellnier DA
    Clin Cancer Res; 2005 Jun; 11(11):4241-50. PubMed ID: 15930363
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Escherichia coli gpt gene sensitizes rat glioma cells to killing by 6-thioxanthine or 6-thioguanine.
    Tamiya T; Ono Y; Wei MX; Mroz PJ; Moolten FL; Chiocca EA
    Cancer Gene Ther; 1996; 3(3):155-62. PubMed ID: 8725879
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Minimally invasive photodynamic therapy (PDT) for ablation of experimental rat glioma.
    Hirschberg H; Spetalen S; Carper S; Hole P; Tillung T; Madsen S
    Minim Invasive Neurosurg; 2006 Jun; 49(3):135-42. PubMed ID: 16921452
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of photodynamic therapy combined with methotrexate on C6 rat glioma cells: a preliminary study.
    LoRusso AP; Yu W; Naim JO; Lanzafame RJ
    J Clin Laser Med Surg; 1996 Apr; 14(2):55-8. PubMed ID: 9484076
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Anthracycline derivatives as photosensitizing agents in photodynamic laser therapy: an in vitro study with squamous epithelial cancer cells of the mouth cavity].
    Lippert BM; Werner JA; Görögh T; Schade W; Rudert H
    Laryngorhinootologie; 1993 Feb; 72(2):63-6. PubMed ID: 8461099
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Protective effect of cholesterol on Friend leukemic cells against photosensitization by hematoporphyrin derivative.
    Salzberg S; Lejbkowicz F; Ehrenberg B; Malik Z
    Cancer Res; 1985 Jul; 45(7):3305-10. PubMed ID: 3859368
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cellular uptake, localization and photodynamic effects of haematoporphyrin derivative in human glioma and squamous carcinoma cell lines.
    Gupta S; Dwarakanath BS; Muralidhar K; Jain V
    J Photochem Photobiol B; 2003 Feb; 69(2):107-20. PubMed ID: 12633983
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intrathecal chemotherapy with MX2 for treating glioma dissemination in vivo.
    Mizumatsu S; Matsumoto K; Ono Y; Tamiya T; Furuta T; Ohmoto T
    J Neurooncol; 2000 Aug; 49(1):41-7. PubMed ID: 11131985
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of DNA-binding in the cytotoxicity of an anthracycline, R20X2 and its morpholino analog, MX2.
    Komeshima N; Kawai H; Nakajima S; Watanabe M; Tsuruo T; Takeuchi T; Otake N
    J Antibiot (Tokyo); 1989 Sep; 42(9):1424-9. PubMed ID: 2793595
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A phase II study of KRN8602(MX2), a novel morpholino anthracycline derivative, in patients with recurrent malignant glioma.
    Kuratsu J; Arita N; Kurisu K; Uozumi T; Hayakawa T; Ushio Y
    J Neurooncol; 1999 Apr; 42(2):177-81. PubMed ID: 10421076
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The inhibitory effect of photodynamic therapy and of an anti-VCAM-1 monoclonal antibody on the in vivo growth of C6 glioma xenografts.
    Zhan Q; Yue W; Shaoshan H
    Braz J Med Biol Res; 2011 May; 44(5):489-90. PubMed ID: 21519637
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Enhancement of radiosensitivity by tamoxifen in C6 glioma cells.
    Zhang W; Yamada H; Sakai N; Niikawa S; Nozawa Y
    Neurosurgery; 1992 Oct; 31(4):725-9; discussion 729-30. PubMed ID: 1407459
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The structure and antitumor activity of antitumor antibiotics--recent progress].
    Otake N
    Gan To Kagaku Ryoho; 1988 Mar; 15(3):369-79. PubMed ID: 3279909
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Determination of the new morpholino anthracycline MX2.HCl and its metabolites in biological samples by high-performance liquid chromatography.
    Shinkai H; Takahashi H; Kikuchi K; Kawai H; Otake N
    J Chromatogr; 1991 Sep; 570(1):203-8. PubMed ID: 1797829
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Enhancement of the efficiency of photodynamic therapy of tumours by t-butyl-4-hydroxyanisole.
    Shevchuk I; Chekulayev V; Chekulayeva L
    J Photochem Photobiol B; 1998 Sep; 45(2-3):136-43. PubMed ID: 9868804
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Haematoporphyrin derivative--photodynamic therapy of colorectal carcinoma, sensitized using verapamil and adriamycin.
    Purkiss SF; Grahn MF; Williams NS
    Surg Oncol; 1996 Aug; 5(4):169-75. PubMed ID: 9067565
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.